Ligand · K17
K17 · 4,5,6,7-tetrabromo-benzimidazole
K17, 4,5,6,7-tetrabromo-benzimidazole (C7 H2 Br4 N2, 433.7 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands…
- Component
- K17
- Formula
- C7 H2 Br4 N2
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
K17 in 4 structures; the first of them:
- 2OXY · Protein kinase CK2 in complex with tetrabromobenzoimidazole derivatives K17, K22 and K32 · K17 A1001 · binds VAL45, VAL53, ILE66, VAL95, PHE113, GLU114, VAL116, ASN118 and 2 more
- 4U7G · Oxidized qui reductase 2 in complex with CK2 inhibitor TBBz · K17 A303 · binds TRP105, PHE106, GLY149, GLY150, MET154, TYR155, ASN161, PHE126 and 2 more
- 2OXY · Protein kinase CK2 in complex with tetrabromobenzoimidazole derivatives K17, K22 and K32 · K17 A1001 · binds VAL45, VAL53, ILE66, VAL95, PHE113, GLU114, VAL116, ASN118 and 2 more
- 4U7G · Oxidized quinone reductase 2 in complex with CK2 inhibitor tbbz · K17 A303 · binds TRP105, PHE106, GLY149, GLY150, MET154, TYR155, ASN161, PHE126 and 2 more
Residues it binds most
PHE 8, VAL 4, GLY 4, ASN 8, ILE 4, MET 8, GLU 4, TRP 4, TYR 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.